# Amycretin oral phase 1 trial: safety and side effects

Source: https://pepvault.app/research/amycretin-gasiorek-2025

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Amycretin](https://pepvault.app/research#amycretin)

Randomized trial · people

# Amycretin: side effects all mild or moderate in first human trial

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

This is the first human safety data for oral amycretin. Side effects were mild or moderate and mostly gut-related, but the study does not establish how much weight the drug takes off.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 144
- **Published:** 2025
- **Journal:** Lancet

## What they tested

The team tested whether amycretin tablets, a single molecule that acts on both GLP-1 and amylin receptors, were safe and well tolerated in people for the first time, and how the drug's blood levels behaved across doses.

## How the study was done

A randomized, double-blind, placebo-controlled phase 1 trial in 144 adults aged 18-55 with overweight or obesity at one research site in San Antonio, Texas. It had three parts: single doses from 1 mg to 25 mg, daily doses of 3 mg, 6 mg or 12 mg for 10 days, and a 12-week regimen with doses stepped up as high as 2 × 50 mg a day, each compared against placebo (a dummy tablet).

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking amycretin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

Across all parts, 89 (62%) of 144 people had at least one adverse event, meaning any health problem that came up during the study, with 364 events in total. Every event was mild or moderate, and events became more common at higher doses. Gastrointestinal events were the most common type, making up 180 (49%) of the 364 events and affecting 72 (81%) of the 89 people who had any event. There were no deaths, and amycretin blood levels rose in proportion to the dose.

## What it doesn’t show

This was a small, early safety trial at a single site, lasting at most 12 weeks of treatment. Its main goal was safety rather than weight loss. Weight and blood sugar were only exploratory measures, and the study was funded by Novo Nordisk.

## The paper

Gasiorek et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial. Lancet. 2025.

- [PubMed (PMID 40550229)](https://pubmed.ncbi.nlm.nih.gov/40550229/)
- [The paper (DOI 10.1016/S0140-6736(25)01176-6)](https://doi.org/10.1016/S0140-6736%2825%2901176-6)
- [ClinicalTrials.gov (NCT05369390)](https://clinicaltrials.gov/study/NCT05369390)

## The compound

- [Amycretin: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/amycretin)
- [Amycretin dose guide](https://pepvault.app/lab/dosage/amycretin)

## With this study

### Amycretin

- [Amycretin: the full reference](https://pepvault.app/peptides/amycretin)
- [Amycretin dose guide](https://pepvault.app/lab/dosage/amycretin)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/amycretin-10mg)

### Studies

- [Amycretin: oral 50 mg arm cut HbA1c by 1.4% at 36 weeks](https://pepvault.app/research/amycretin-mora-2026)
- [Amycretin: HbA1c fell up to 1.7% at 36 weeks in type 2 diabetes](https://pepvault.app/research/amycretin-mora-2026-42532080)
- [Amycretin: 24.3% weight loss at 36 weeks in a phase 1b/2a trial](https://pepvault.app/research/amycretin-dahl-2025)
- [All 6 studies](https://pepvault.app/research#amycretin)

### Compared with

- [CagriSema vs Amycretin](https://pepvault.app/peptides/compare/cagrisema-vs-amycretin)
- [Semaglutide vs Amycretin](https://pepvault.app/peptides/compare/semaglutide-vs-amycretin)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)

## More studies on Amycretin

- [Amycretin: oral 50 mg arm cut HbA1c by 1.4% at 36 weeks](https://pepvault.app/research/amycretin-mora-2026) Randomized trial · people · 2026
- [Amycretin: HbA1c fell up to 1.7% at 36 weeks in type 2 diabetes](https://pepvault.app/research/amycretin-mora-2026-42532080) Randomized trial · people · 2026
- [Amycretin: 24.3% weight loss at 36 weeks in a phase 1b/2a trial](https://pepvault.app/research/amycretin-dahl-2025) Randomized trial · people · 2025
- [Amycretin: similar drug exposure with kidney impairment in phase 1](https://pepvault.app/research/amycretin-oldenburg-2026) Clinical trial · people · 2026
- [Amycretin cut body weight by 18% in obese rats over 21 days](https://pepvault.app/research/amycretin-kuhre-2025) Animal study · mice and rats · 2025
- [Every study on Amycretin](https://pepvault.app/research#amycretin)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking amycretin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking amycretin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Amycretin

- [Amycretin: the full reference](https://pepvault.app/peptides/amycretin)
- [Amycretin dose guide](https://pepvault.app/lab/dosage/amycretin)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/amycretin-10mg)

### Studies

- [Amycretin: oral 50 mg arm cut HbA1c by 1.4% at 36 weeks](https://pepvault.app/research/amycretin-mora-2026)
- [Amycretin: HbA1c fell up to 1.7% at 36 weeks in type 2 diabetes](https://pepvault.app/research/amycretin-mora-2026-42532080)
- [Amycretin: 24.3% weight loss at 36 weeks in a phase 1b/2a trial](https://pepvault.app/research/amycretin-dahl-2025)
- [All 6 studies](https://pepvault.app/research#amycretin)

### Compared with

- [CagriSema vs Amycretin](https://pepvault.app/peptides/compare/cagrisema-vs-amycretin)
- [Semaglutide vs Amycretin](https://pepvault.app/peptides/compare/semaglutide-vs-amycretin)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)

<!--promo-->

PepVault for iPhone

## Taking amycretin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Amycretin](https://pepvault.app/research#amycretin)

## The library

- [Amycretin](https://pepvault.app/peptides/amycretin)
- [Amycretin dose guide](https://pepvault.app/lab/dosage/amycretin)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
